EdgarLookup

HF Sinclair Corp — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that HF Sinclair Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
2.2%
Profit Margin
Net income ÷ revenue
3.5%
Return on Assets
Net income ÷ assets
0.79x
Debt-to-Equity
Total liabilities ÷ equity
-6%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $26.87B Feb 27, 2026
FY2025 Dec 31, 2024 $28.58B Feb 27, 2026
FY2025 Dec 31, 2023 $31.96B Feb 27, 2026
FY2024 Dec 31, 2022 $38.21B Feb 20, 2025
FY2023 Dec 31, 2021 $18.39B Feb 21, 2024
FY2022 Dec 31, 2020 $11.18B Feb 28, 2023

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $579.00M Feb 27, 2026
FY2025 Dec 31, 2024 $177.00M Feb 27, 2026
FY2025 Dec 31, 2023 $1.59B Feb 27, 2026
FY2024 Dec 31, 2022 $2.92B Feb 20, 2025
FY2023 Dec 31, 2021 $558.32M Feb 21, 2024
FY2022 Dec 31, 2020 ($601.45M) Feb 28, 2023

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $927.00M Feb 27, 2026
FY2025 Dec 31, 2024 $261.00M Feb 27, 2026
FY2025 Dec 31, 2023 $2.20B Feb 27, 2026
FY2024 Dec 31, 2022 $4.05B Feb 20, 2025
FY2023 Dec 31, 2021 $749.19M Feb 21, 2024
FY2022 Dec 31, 2020 ($733.74M) Feb 28, 2023

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $456.00M Feb 27, 2026
FY2025 Dec 31, 2024 $447.00M Feb 27, 2026
FY2025 Dec 31, 2023 $497.00M Feb 27, 2026
FY2024 Dec 31, 2022 $427.00M Feb 20, 2025
FY2023 Dec 31, 2021 $362.01M Feb 21, 2024
FY2022 Dec 31, 2020 $313.60M Feb 28, 2023

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.32B Feb 27, 2026
FY2025 Dec 31, 2024 $1.11B Feb 27, 2026
FY2025 Dec 31, 2023 $2.30B Feb 27, 2026
FY2024 Dec 31, 2022 $3.78B Feb 20, 2025
FY2023 Dec 31, 2021 $406.68M Feb 21, 2024
FY2022 Dec 31, 2020 $457.93M Feb 28, 2023

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $449.00M Feb 27, 2026
FY2025 Dec 31, 2024 $470.00M Feb 27, 2026
FY2025 Dec 31, 2023 $385.00M Feb 27, 2026
FY2024 Dec 31, 2022 $524.00M Feb 20, 2025
FY2023 Dec 31, 2021 $725.07M Feb 21, 2024
FY2022 Dec 31, 2020 $270.88M Feb 28, 2023

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $16.51B Feb 27, 2026
FY2025 Dec 31, 2024 $16.64B Feb 27, 2026
FY2024 Dec 31, 2023 $17.72B Feb 20, 2025
FY2023 Dec 31, 2022 $18.13B Feb 21, 2024
FY2022 Dec 31, 2021 $12.92B Feb 28, 2023

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.26B Feb 27, 2026
FY2025 Dec 31, 2024 $7.30B Feb 27, 2026
FY2024 Dec 31, 2023 $7.48B Feb 20, 2025

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $9.18B Feb 27, 2026
FY2025 Dec 31, 2024 $9.28B Feb 27, 2026
FY2024 Dec 31, 2023 $10.17B Feb 20, 2025
FY2023 Dec 31, 2022 $9.24B Feb 21, 2024
FY2022 Dec 31, 2021 $5.69B Feb 28, 2023

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.98B Feb 27, 2026
FY2025 Dec 31, 2024 $2.98B Feb 27, 2026
FY2025 Dec 31, 2023 $2.98B Feb 27, 2026
FY2024 Dec 31, 2022 $2.98B Feb 20, 2025
FY2022 Dec 31, 2021 $2.29B Feb 28, 2023

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.37B Feb 27, 2026
FY2025 Dec 31, 2024 $5.17B Feb 27, 2026
FY2024 Dec 31, 2023 $5.38B Feb 20, 2025
FY2023 Dec 31, 2022 $4.13B Feb 21, 2024
FY2022 Dec 31, 2021 $4.41B Feb 28, 2023

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $978.00M Feb 27, 2026
FY2025 Dec 31, 2024 $800.00M Feb 27, 2026
FY2024 Dec 31, 2023 $1.35B Feb 20, 2025
FY2023 Dec 31, 2022 $1.67B Feb 21, 2024
FY2022 Dec 31, 2021 $234.44M Feb 28, 2023

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.77B Feb 27, 2026
FY2025 Dec 31, 2024 $2.64B Feb 27, 2026
FY2023 Dec 31, 2023 $2.76B Feb 21, 2024
FY2022 Dec 31, 2022 $3.28B Feb 28, 2023

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 3 Feb 27, 2026
FY2025 Dec 31, 2024 0 Feb 27, 2026
FY2025 Dec 31, 2023 8 Feb 27, 2026
FY2024 Dec 31, 2022 14 Feb 20, 2025
FY2023 Dec 31, 2021 3 Feb 21, 2024
FY2022 Dec 31, 2020 (3) Feb 28, 2023

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 3 Feb 27, 2026
FY2025 Dec 31, 2024 0 Feb 27, 2026
FY2025 Dec 31, 2023 8 Feb 27, 2026
FY2024 Dec 31, 2022 14 Feb 20, 2025
FY2023 Dec 31, 2021 3 Feb 21, 2024
FY2022 Dec 31, 2020 (3) Feb 28, 2023

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $376.00M Feb 27, 2026
FY2025 Dec 31, 2024 $386.00M Feb 27, 2026
FY2025 Dec 31, 2023 $341.00M Feb 27, 2026
FY2024 Dec 31, 2022 $256.00M Feb 20, 2025
FY2023 Dec 31, 2021 $57.66M Feb 21, 2024
FY2022 Dec 31, 2020 $229.49M Feb 28, 2023